View ValuationIntercos 将来の成長Future 基準チェック /36Intercos利益と収益がそれぞれ年間16.8%と5.4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に14.9% 16.9%なると予測されています。主要情報16.8%収益成長率16.87%EPS成長率Personal Products 収益成長8.0%収益成長率5.4%将来の株主資本利益率14.87%アナリストカバレッジGood最終更新日13 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • May 05Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 3.7% to €13.04. The fair value is estimated to be €10.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.5% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.Upcoming Dividend • Apr 27Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 04 May 2026. Payment date: 06 May 2026. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.6%).Buy Or Sell Opportunity • Apr 07Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.Buy Or Sell Opportunity • Mar 16Now 28% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to €13.04. The fair value is estimated to be €10.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.Declared Dividend • Mar 08Dividend of €0.20 announcedDividend of €0.20 is the same as last year. Ex-date: 4th May 2026 Payment date: 6th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (16% cash payout ratio). The dividend has increased by an average of 5.9% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 43% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 07Intercos S.p.A. announces Annual dividend, payable on May 06, 2026Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 06, 2026, ex-date on May 04, 2026 and record date on May 05, 2026.Reported Earnings • Mar 07Full year 2025 earnings releasedFull year 2025 results: Revenue: €1.05b (down 1.7% from FY 2024). Net income: €50.1m (up 3.2% from FY 2024). Profit margin: 4.8% (up from 4.6% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Personal Products industry in the United Kingdom.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.23 per share.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.48 per share.お知らせ • Dec 18+ 3 more updatesIntercos S.p.A. to Report Q1, 2026 Results on May 07, 2026Intercos S.p.A. announced that they will report Q1, 2026 results on May 07, 2026New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.41 per share.Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.82 per share.Buy Or Sell Opportunity • Oct 29Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to €13.04. The fair value is estimated to be €10.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 7.1% in 2 years. Earnings are forecast to grow by 61% in the next 2 years.Buy Or Sell Opportunity • Oct 13Now 30% overvalued after recent price riseOver the last 90 days, the stock has risen 6.4% to €13.04. The fair value is estimated to be €10.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 6.9% in 2 years. Earnings are forecast to grow by 58% in the next 2 years.Buy Or Sell Opportunity • Sep 08Now 31% overvaluedOver the last 90 days, the stock has fallen 3.8% to €13.04. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 8.6% in 2 years. Earnings are forecast to grow by 62% in the next 2 years.Reported Earnings • Aug 11First half 2025 earnings released: EPS: €0.17 (vs €0.18 in 1H 2024)First half 2025 results: EPS: €0.17 (down from €0.18 in 1H 2024). Revenue: €524.9m (up 5.0% from 1H 2024). Net income: €16.5m (down 6.9% from 1H 2024). Profit margin: 3.1% (down from 3.5% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Jul 30Now 27% overvaluedOver the last 90 days, the stock has fallen 1.7% to €13.04. The fair value is estimated to be €10.24, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.Buy Or Sell Opportunity • Jul 15Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 9.4% to €13.04. The fair value is estimated to be €10.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.Buy Or Sell Opportunity • May 09Now 22% overvaluedOver the last 90 days, the stock has fallen 2.3% to €13.20. The fair value is estimated to be €10.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.Upcoming Dividend • Apr 28Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 05 May 2025. Payment date: 07 May 2025. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (6.0%). Lower than average of industry peers (2.3%).Buy Or Sell Opportunity • Apr 23Now 22% overvaluedOver the last 90 days, the stock has fallen 9.1% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.Declared Dividend • Mar 08Dividend increased to €0.20Dividend of €0.20 is 5.4% higher than last year. Ex-date: 5th May 2025 Payment date: 7th May 2025 Dividend yield will be 1.5%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 8.9% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 39% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Mar 06Full year 2024 earnings releasedFull year 2024 results: Revenue: €1.06b (up 7.8% from FY 2023). Net income: €48.8m (down 6.8% from FY 2023). Profit margin: 4.6% (down from 5.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in the United Kingdom.お知らせ • Mar 06Intercos S.p.A. announces Annual dividend, payable on May 07, 2025Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 07, 2025, ex-date on May 05, 2025 and record date on May 06, 2025.お知らせ • Jan 07+ 3 more updatesIntercos S.p.A. to Report First Half, 2025 Results on Aug 04, 2025Intercos S.p.A. announced that they will report first half, 2025 results on Aug 04, 2025Reported Earnings • Aug 05First half 2024 earnings releasedFirst half 2024 results: Revenue: €499.9m (up 2.4% from 1H 2023). Net income: €17.9m (down 28% from 1H 2023). Profit margin: 3.6% (down from 5.1% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.Buy Or Sell Opportunity • Aug 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €16.44. The fair value is estimated to be €13.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 77% in the next 2 years.Reported Earnings • May 11First quarter 2024 earnings released: EPS: €0.05 (vs €0.13 in 1Q 2023)First quarter 2024 results: EPS: €0.05 (down from €0.13 in 1Q 2023). Revenue: €403.8m (up 65% from 1Q 2023). Net income: €2.81m (down 77% from 1Q 2023). Profit margin: 0.7% (down from 5.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom.お知らせ • Mar 27Intercos S.p.A. to Report Fiscal Year 2023 Results on Apr 11, 2024Intercos S.p.A. announced that they will report fiscal year 2023 results on Apr 11, 2024Declared Dividend • Mar 07Dividend increased to €0.19Dividend of €0.19 is 12% higher than last year. Ex-date: 6th May 2024 Payment date: 8th May 2024 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 31%. Cash payout ratio: 35%.お知らせ • Dec 18+ 4 more updatesIntercos S.p.A., Annual General Meeting, Apr 11, 2024Intercos S.p.A., Annual General Meeting, Apr 11, 2024. Agenda: To discuss the Financial Statements at 31 December 2023.Reported Earnings • Aug 06First half 2023 earnings releasedFirst half 2023 results: Revenue: €488.4m (up 33% from 1H 2022). Net income: €25.0m (up 38% from 1H 2022). Profit margin: 5.1% (up from 4.9% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.Valuation Update With 7 Day Price Move • Jul 17Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 21x in the Personal Products industry in Europe.Board Change • Jul 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jun 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • May 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Personal Products industry in Europe.Valuation Update With 7 Day Price Move • Apr 19Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €16.10, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Personal Products industry in Europe.Reported Earnings • Mar 16Full year 2022 earnings releasedFull year 2022 results: Revenue: €835.6m (up 24% from FY 2021). Net income: €45.0m (up 67% from FY 2021). Profit margin: 5.4% (up from 4.0% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.お知らせ • Feb 13Intercos S.p.A. to Report Fiscal Year 2022 Results on Mar 14, 2023Intercos S.p.A. announced that they will report fiscal year 2022 results on Mar 14, 2023Board Change • Jan 25Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Nov 30Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 26Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €10.84, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €8.85 per share.Board Change • Oct 14Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 01Investor sentiment improved over the past weekAfter last week's 22% share price gain to €13.04, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €12.42 per share.Board Change • Sep 01Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Aug 06First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down €17.5m from profit in 1H 2021). Profit margin: (down from 5.5% in 1H 2021). Over the next year, revenue is forecast to grow 11%, compared to a 5.7% growth forecast for the industry in the United Kingdom.Board Change • Jul 22Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jun 08Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 8 non-independent directors. Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.業績と収益の成長予測LSE:0AAR - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281,2298670142912/31/20271,1667761133912/31/20261,1036848125912/31/20251,0475049119N/A9/30/20251,0694933104N/A6/30/20251,090471689N/A3/31/20251,077482594N/A12/31/20241,065493499N/A9/30/20241,032473997N/A6/30/20241,000454395N/A3/31/2024994494599N/A12/31/20239885248103N/A9/30/20239725250104N/A6/30/20239565252104N/A3/31/2023896484291N/A12/31/2022836453277N/A9/30/2022781361659N/A6/30/202272728141N/A3/31/2022700271251N/A12/31/2021674272362N/A9/30/2021659304686N/A6/30/20216443270111N/A3/31/20216253560101N/A12/31/2020607385091N/A9/30/20206344165108N/A6/30/2020643482873N/A3/31/2020679454995N/A12/31/2019713434084N/A9/30/201970352N/A82N/A6/30/201970450N/A101N/A3/31/201970956N/A80N/A12/31/201869247N/A83N/A9/30/201868034N/A82N/A6/30/201867631N/A49N/A3/31/201862623N/A61N/A12/31/201759026N/A62N/A9/30/201755232N/A41N/A6/30/201749527N/A62N/A3/31/201746923N/A54N/A12/31/201644920N/A53N/A9/30/201642916N/A56N/A6/30/201642920N/A51N/A3/31/201641919N/A56N/A12/31/201540215N/A64N/A9/30/20153827N/A45N/A6/30/20153570N/A42N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0AARの予測収益成長率 (年間16.8% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 0AARの収益 ( 16.8% ) はUK市場 ( 11.5% ) よりも速いペースで成長すると予測されています。高成長収益: 0AARの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 0AARの収益 ( 5.4% ) UK市場 ( 4.5% ) よりも速いペースで成長すると予測されています。高い収益成長: 0AARの収益 ( 5.4% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0AARの 自己資本利益率 は、3年後には低くなると予測されています ( 14.9 %)。成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 08:13終値2026/06/09 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Intercos S.p.A. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14 アナリスト機関Paola SagliettiBanca Akros S.p.A. (ESN)Anna FrontaniBerenbergMikheil OmanadzeBNP Paribas11 その他のアナリストを表示
Buy Or Sell Opportunity • May 05Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 3.7% to €13.04. The fair value is estimated to be €10.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.5% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.
Upcoming Dividend • Apr 27Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 04 May 2026. Payment date: 06 May 2026. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.6%).
Buy Or Sell Opportunity • Apr 07Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.
Buy Or Sell Opportunity • Mar 16Now 28% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to €13.04. The fair value is estimated to be €10.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.
Declared Dividend • Mar 08Dividend of €0.20 announcedDividend of €0.20 is the same as last year. Ex-date: 4th May 2026 Payment date: 6th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (16% cash payout ratio). The dividend has increased by an average of 5.9% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 43% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 07Intercos S.p.A. announces Annual dividend, payable on May 06, 2026Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 06, 2026, ex-date on May 04, 2026 and record date on May 05, 2026.
Reported Earnings • Mar 07Full year 2025 earnings releasedFull year 2025 results: Revenue: €1.05b (down 1.7% from FY 2024). Net income: €50.1m (up 3.2% from FY 2024). Profit margin: 4.8% (up from 4.6% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Personal Products industry in the United Kingdom.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.23 per share.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.48 per share.
お知らせ • Dec 18+ 3 more updatesIntercos S.p.A. to Report Q1, 2026 Results on May 07, 2026Intercos S.p.A. announced that they will report Q1, 2026 results on May 07, 2026
New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.41 per share.
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.82 per share.
Buy Or Sell Opportunity • Oct 29Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to €13.04. The fair value is estimated to be €10.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 7.1% in 2 years. Earnings are forecast to grow by 61% in the next 2 years.
Buy Or Sell Opportunity • Oct 13Now 30% overvalued after recent price riseOver the last 90 days, the stock has risen 6.4% to €13.04. The fair value is estimated to be €10.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 6.9% in 2 years. Earnings are forecast to grow by 58% in the next 2 years.
Buy Or Sell Opportunity • Sep 08Now 31% overvaluedOver the last 90 days, the stock has fallen 3.8% to €13.04. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 8.6% in 2 years. Earnings are forecast to grow by 62% in the next 2 years.
Reported Earnings • Aug 11First half 2025 earnings released: EPS: €0.17 (vs €0.18 in 1H 2024)First half 2025 results: EPS: €0.17 (down from €0.18 in 1H 2024). Revenue: €524.9m (up 5.0% from 1H 2024). Net income: €16.5m (down 6.9% from 1H 2024). Profit margin: 3.1% (down from 3.5% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Jul 30Now 27% overvaluedOver the last 90 days, the stock has fallen 1.7% to €13.04. The fair value is estimated to be €10.24, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.
Buy Or Sell Opportunity • Jul 15Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 9.4% to €13.04. The fair value is estimated to be €10.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.
Buy Or Sell Opportunity • May 09Now 22% overvaluedOver the last 90 days, the stock has fallen 2.3% to €13.20. The fair value is estimated to be €10.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
Upcoming Dividend • Apr 28Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 05 May 2025. Payment date: 07 May 2025. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (6.0%). Lower than average of industry peers (2.3%).
Buy Or Sell Opportunity • Apr 23Now 22% overvaluedOver the last 90 days, the stock has fallen 9.1% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 18% per annum over the same time period.
Declared Dividend • Mar 08Dividend increased to €0.20Dividend of €0.20 is 5.4% higher than last year. Ex-date: 5th May 2025 Payment date: 7th May 2025 Dividend yield will be 1.5%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 8.9% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 39% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Mar 06Full year 2024 earnings releasedFull year 2024 results: Revenue: €1.06b (up 7.8% from FY 2023). Net income: €48.8m (down 6.8% from FY 2023). Profit margin: 4.6% (down from 5.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in the United Kingdom.
お知らせ • Mar 06Intercos S.p.A. announces Annual dividend, payable on May 07, 2025Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 07, 2025, ex-date on May 05, 2025 and record date on May 06, 2025.
お知らせ • Jan 07+ 3 more updatesIntercos S.p.A. to Report First Half, 2025 Results on Aug 04, 2025Intercos S.p.A. announced that they will report first half, 2025 results on Aug 04, 2025
Reported Earnings • Aug 05First half 2024 earnings releasedFirst half 2024 results: Revenue: €499.9m (up 2.4% from 1H 2023). Net income: €17.9m (down 28% from 1H 2023). Profit margin: 3.6% (down from 5.1% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.
Buy Or Sell Opportunity • Aug 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €16.44. The fair value is estimated to be €13.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 77% in the next 2 years.
Reported Earnings • May 11First quarter 2024 earnings released: EPS: €0.05 (vs €0.13 in 1Q 2023)First quarter 2024 results: EPS: €0.05 (down from €0.13 in 1Q 2023). Revenue: €403.8m (up 65% from 1Q 2023). Net income: €2.81m (down 77% from 1Q 2023). Profit margin: 0.7% (down from 5.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom.
お知らせ • Mar 27Intercos S.p.A. to Report Fiscal Year 2023 Results on Apr 11, 2024Intercos S.p.A. announced that they will report fiscal year 2023 results on Apr 11, 2024
Declared Dividend • Mar 07Dividend increased to €0.19Dividend of €0.19 is 12% higher than last year. Ex-date: 6th May 2024 Payment date: 8th May 2024 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 31%. Cash payout ratio: 35%.
お知らせ • Dec 18+ 4 more updatesIntercos S.p.A., Annual General Meeting, Apr 11, 2024Intercos S.p.A., Annual General Meeting, Apr 11, 2024. Agenda: To discuss the Financial Statements at 31 December 2023.
Reported Earnings • Aug 06First half 2023 earnings releasedFirst half 2023 results: Revenue: €488.4m (up 33% from 1H 2022). Net income: €25.0m (up 38% from 1H 2022). Profit margin: 5.1% (up from 4.9% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.
Valuation Update With 7 Day Price Move • Jul 17Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 21x in the Personal Products industry in Europe.
Board Change • Jul 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jun 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • May 31Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Personal Products industry in Europe.
Valuation Update With 7 Day Price Move • Apr 19Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €16.10, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Personal Products industry in Europe.
Reported Earnings • Mar 16Full year 2022 earnings releasedFull year 2022 results: Revenue: €835.6m (up 24% from FY 2021). Net income: €45.0m (up 67% from FY 2021). Profit margin: 5.4% (up from 4.0% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.
お知らせ • Feb 13Intercos S.p.A. to Report Fiscal Year 2022 Results on Mar 14, 2023Intercos S.p.A. announced that they will report fiscal year 2022 results on Mar 14, 2023
Board Change • Jan 25Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Nov 30Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 26Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €10.84, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €8.85 per share.
Board Change • Oct 14Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 01Investor sentiment improved over the past weekAfter last week's 22% share price gain to €13.04, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €12.42 per share.
Board Change • Sep 01Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 06First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down €17.5m from profit in 1H 2021). Profit margin: (down from 5.5% in 1H 2021). Over the next year, revenue is forecast to grow 11%, compared to a 5.7% growth forecast for the industry in the United Kingdom.
Board Change • Jul 22Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jun 08Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 8 non-independent directors. Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.